Prof.Dr.Salih PAY'ın ULUSLARARASI BİLDİRİLERİ

     CV sayfası             ANA SAYFA

  

   

1.     S. Soysal MD, M. Kutlu MD, S. Pay MD, C. Gönlüşen MD, F. Kocabalkan MD. Toxoplasma enfections in patients with SLE. 29. International Congress of Military Medicine, 18-25 September 1993

2.     S. Karaova MD, S. Pay MD, A. Uygun MD, Ç. Özdemir MD. Evaluation of plasma dopamine beta hydroxylase levels in patients with recurrent hereditary polyserositis. 29. International Congress of Military Medicine, 18-25 September 1993

3.     S. Pay MD, N Özcan MD, L. Tokgözoğlu MD, A. Z. Çalışkaner MD. Lipid, lipoprotein and apolipoprotein disorders in patients with premature coronary disease. Turkish-German Joint Meeting on Hypertension & Atherosclerosis, 21-25 April 1996

4.     S. Pay MD, N Özcan MD, L. Tokgözoğlu MD, A. Z. Çalışkaner MD. Familial lipid and lipoprotein disorders in patients with premature coronary disease. Turkish-German Joint Meeting on Hypertension & Atherosclerosis, 21-25 April 1996

5.     Z. Çalışkaner MD, S. Pay MD, M.Turan MD, A. Dinç MD, Y. Baykal MD, F. Kocabalkan MD. Clinical characteristics of familial Mediterranean fever. 8th Mediterranean Congress of Rheumatology, 24-26 June 1996

6.     M.Turan MD, İ. H. Koçer MD, T. Plevneli MD, S. Pay MD, Y. Baykal MD, F. Kocabalkan MD. Heart involvement in scleroderma. 8th Mediterranean Congress of Rheumatology, 24-26 June 1996

7.     Z. Çalışkaner MD, S. Pay MD, A. Dinç MD, Y. Baykal MD, M.Turan MD, F. Kocabalkan MD. Clinical evaluation of hypersensitivity vasculitis. 8th Mediterranean Congress of Rheumatology, 24-26 June 1996

8.     S. Nalbant MD, Ü. Ateşkan MD, R. Mas MD, Y. Baykal MD, A. Dinç MD, S. Pay MD. Clinical usage of serum complement. 8th Mediterranean Congress of Rheumatology, 24-26 June 1996

9.     C. Top MD, Y. Baykal MD, M. Karaayvaz MD, B. Koç MD, S. Pay MD, Z. Çalışkaner MD, T. Ünal MD, F. Kocabalkan MD. Parvavirus B19 antibodies in vasculitis syndrome. 8th Mediterranean Congress of Rheumatology, 24-26 June 1996

10.  S. Kiraz MD, İ. Ertenli MD, M. Çalgüneri MD, S. Pay MD, M. Erman MD, İ. Çelik MD, İ. Haznedaroğlu MD, Ş. Kirazlı. Effects of colchicine treatment on inflammatory cytokines and selectins in familial Mediterranean fever. 1st International Conference on Familial Mediterranean Fever (FMF), 7-11 September 1997

11.  M. Çalgüneri MD, Ş. Apraş MD, S. Pay MD, İ. Ertenli MD, S. Kiraz MD, V. Çobankara MD. D-Penicillamine versus cyclophosphammide plus low dose prednisolone therapy in early diffuse systemic sclerosis. 11th EULAR Symposium, 5-8 September 1998

12.  M. Çalgüneri MD, S. Pay MD, Ş. Apraş MD, S. Kiraz MD, İ. Ertenli MD, V. Çobankara MD. Combination therapy in rheumatoid arthritis. 11th EULAR Symposium, 5-8 September 1998

13.  S. Kiraz MD, İ. Ertenli MD, M. Çalgüneri MD, İ Haznedaroğlu MD, M. Erman MD, S. Pay MD, Ş. Apraş MD, Ş Kirazlı. Plasminogen activator inhibitor-1 in the synovial fluıd of Behçet’s disease. 11th EULAR Symposium, 5-8 September 1998

14.  İ. Ertenli MD, S. Kiraz MD, M. Çalgüneri MD, İ. Haznedaroğlu MD, M. Erman MD, Ş. Apraş MD,  S. Pay MD, Ş Kirazlı. Thrombopoietin in progressive systemic sclerosis. 11th EULAR Symposium, 5-8 September 1998

15.  Z. Çalışkaner MD, S. Pay MD, A. Dinç MD, Y. Baykal MD, İ.H. Koçer MD. Clostridium difficili as a causative agent for reactive arthritis. 11th EULAR Symposium, 5-8 September 1998

16. M. Çalgüneri MD, S. Pay MD, Ş. Apraş MD, S. Kiraz MD, İ. Ertenli MD, V. Çobankara MD. Pituitary function in patients with primary fibromyalgia. 14th EULAR Congress, 6-11 June 1999

17.  M. Çalgüneri MD, S. Pay MD, İ. Ünsal MD, İ. Ertenli MD, V. Çobankara MD, Ş. Apraş MD, S. Kiraz MD. Clinical, laboratory and radiologic evaluation of premenauposal female patients with chronic widespread musculoskeletal complaints.  14th EULAR Congress, 6-11 June 1999

18.  M. Çalgüneri MD, S. Pay MD, İ. Ertenli MD, V. Çobankara MD, Ş. Apraş MD, S. Kiraz MD. Thyroid functions and thyroid autoantibodies in patients with primary fibromyalgia. 14th EULAR Congress, 6-11 June 1999

19.  M. Çalgüneri MD, S. Pay MD, S. Kiraz MD, İ. Ertenli MD, V. Çobankara MD, Ş. Apraş MD. Clinical findings and carpal tunnel syndrome in patients with primary fibromyalgia. 14th EULAR Congress, 6-11 June 1999

20.  S. Kiraz MD, İ. Ertenli MD, M. Çalgüneri MD, İ. Haznedaroğlu MD, S. Pay MD, Ş. Apraş MD, M. Erman MD, S. Dündar MD, Ş. Kirazlı. Superoxide dismutase and nitric oxide levels in Behçet disease. 14th EULAR Congress, 6-11 June 1999

21.  M. Çalgüneri MD, Ş. Apraş MD, A. Yıldırır MD, S. Pay MD, S. Kiraz MD, İ. Ertenli MD, V. Çobankara MD, K. Övünç. A case of Behçet’s disease associated with reccurrent major veins and intracardiac thrombi: Complete recovery with interferon therapy. 14th EULAR Congress, 6-11 June 1999

22. İ. Ertenli MD, S. Kiraz MD, Ş. Apraş MD, S. Pay MD, V. Çobankara MD, M. Çalgüneri MD. Slow release nifedipine in primary Raynaud’s phenomenon. 14th EULAR Congress, 6-11 June 1999

23. S. Kiraz MD, İ. Ertenli MD, M. Çalgüneri MD, Ş. Apraş MD, S. Pay MD, M. Erman MD, İ. Çelik MD. Anticardiolipin antibody and significance with respect to clinical signs in Behçet’s disease. 14th EULAR Congress, 6-11 June 1999

24. S. Kiraz MD, İ. Ertenli MD, S. Dağdelen MD, M. Çalgüneri MD, S. Pay MD, Ş. Apraş MD, M. Erman MD, İ. Çelik MD. İncidence of reactive arthritis after salmonella typhimirium food poisoning outbreak observed in Hacettepe University. 14th EULAR Congress, 6-11 June 1999

25.  N. Özcan MD, S. Pay MD, L. Tokgözoğlu MD, M. Yılmaz MD, Z. Çalışkaner MD. Antidyslipidemic efficacy of oestrogen replacement therapy. European Atherosclerosis Society, 1999 Workshop “Low HDL in Cardiovascular Diseases”, 24-25 September 1999    (ATHEROSCLEROSIS 146: 47 Suppl. 1 SEP 1999)

26.  M. Çalgüneri MD, V. Çobankara MD, M. Erman MD, S. Kiraz MD, İ. Ertenli MD, Ş. Apraş MD, S. Pay MD, M. A. Öztürk MD. Clinical and immunological evaluation of 30 patients with primary Sjögren’s Sendrome. VII International Symposium on Sjögren’s Syndrome. 1-4 December 1999 

27. A. Dinç MD, S. Pay MD, İ. Şimşek MD, K. Çağlar MD (Sözlü). Fabry’s Disease mimicking Familial Mediterranean Fever. Familial Mediterranean Fever II. International Conference, 3-7 May 2000

28. A. Dinç MD, S. Pay MD, M. Turan MD, İ. Şimşek MD (Sözlü). Prevalance of Familial Mediterranean Fever in young Turkism men. Familial Mediterranean Fever II. International Conference, 3-7 May 2000

29. S. Kiraz MD, İ. Ertenli MD, M. Çalgüneri MD, İ. Haznedaroğlu MD, M. Erman MD, S. Pay MD, Ş. Apraş MD, V. Çobankara MD, A. Dinç MD. Selectins during the acute attacks of Familial Mediterranean Fever. Familial Mediterranean Fever II. International Conference, 3-7 May 2000

30. İ. Ertenli MD, S. Kiraz MD, S. Pay MD, M. Çalgüneri MD, İ. Haznedaroğlu MD, M. Erman MD, V. Çobankara MD, Ş. Apraş MD, A. Dinç MD. Serum fibronectin and thrombospondin levels during the acute attacks and attack-free periods of FMF patiens. Familial Mediterranean Fever II. International Conference, 3-7 May 2000

31. S. Pay MD, M. Çalgüneri MD, S. Kiraz MD, İ. Ertenli MD, V. Çobankara MD, Ş. Apraş MD. Evaluation of Vascular Injury with Proinflammatory Cytokines, Thrombomodulin and Fibronectin in Patients with Primary Fibromyalgia. Annual European Congress on Rheumatology-EULAR 2000, 21-24 June 2000

32. A. Dinç MD, M. Soy MD, S. Pay MD, İ. Şimşek MD, H. Erdem MD. A Case of Churg-Strauss Syndrome presenting with cortical blindness. Annual European Congress on Rheumatology-EULAR 2000, 21-24 June 2000

33. S. Pay MD, A. Dinç MD, İ. Şimşek MD, H. Erdem MD, M. Soy MD. Sulphasalazine induced angioimmunoblastic lymphadenopathy. Annual European Congress on Rheumatology-EULAR 2000, 21-24 June 2000

34. A. Dinç MD, S. Pay MD, İ. Şimşek MD, H. Erdem MD. Constrictive cholesterol pericarditis due to rheumatoid arthritis. Annual European Congress on Rheumatology-EULAR 2000, 21-24 June 2000

35. M. Çalgüneri MD, V. Çobankara MD, Ş. Apraş MD, S. Pay MD, S. Kiraz MD, A. Öztürk MD. Combination therapy in sero-negative spondyloarthropaties (SSA) (Sözlü). Annual European Congress on Rheumatology-EULAR 2000, 21-24 June 2000

36. S. Kiraz MD, İ. Ertenli MD, M. Çalgüneri MD, M. Erman MD, İC Haznedaroğlu MD, Ş. Apraş MD, S. Pay MD, V. Çobankara MD, A. Öztürk MD, İ. Çelik MD. Effects of colchicine on serum amiloid-A protein (SAA) in patients with FMF and Behçet’s disease.  Annual European Congress on Rheumatology-EULAR 2000, 21-24 June 2000

37. V. Çobankara MD, D. Özatı MD, Ş. Apraş MD, S. Kiraz MD, İ. Ertenli MD, İC Haznedaroğlu MD, A. Öztürk MD S. Pay MD, M. Çalgüneri MD, Ş. Kirazlı. Circulating serum levels of thrombomodulin and fibronectin in patients with reactive thrombocytosis due to rheumatoid arthritis and iron deficiency anemia. Annual European Congress on Rheumatology-EULAR 2000, 21-24 June 2000

38. M. Çalgüneri MD, İ. Ertenli MD, Ş. Apraş MD, S. Kiraz MD, V. Çobankara MD, S. Pay MD, A. Öztürk MD. Causes of death in patients with systemic lupus erythematosus: Experience of 14 years. Annual European Congress on Rheumatology-EULAR 2000, 21-24 June 2000

39. M. Çalgüneri MD, Ş. Apraş MD, S. Kiraz MD,  İ. Ertenli MD, V. Çobankara MD, S. Pay MD, M. Erman MD, İ. Çelik MD. An analylis of 389 SLE patients with emphasis on the effect of gender on disease manifestations. Annual European Congress on Rheumatology-EULAR 2000, 21-24 June 2000

40. M. Çalgüneri MD, V. Çobankara MD, D. Özat MD, G. Güler MD, Ş. Apraş MD, S. Pay MD, İ. Ertenli MD, S. Kiraz MD. Is visual loss due to giant cell arteritis reversible? Annual European Congress on Rheumatology-EULAR 2000, 21-24 June 2000

41. A. Dinç MD, S. Pay MD, İ. Şimşek MD, H. Erdem MD, K. Çağlar MD, M. Tanyüksel MD, M. R. Mas MD. Polymyosit and toxoplasmosois: An observation in patients with crush syndrome. 64th Annual Scientific Meeting of the American Collage of Rheumatology 2000, October 28-November 2 2000.

42. A. Dinç MD, S. Pay MD, Z. Bayraktar MD, H Erdem MD, M. Turan MD. Cyclosporin A versus interferon alpha in treatment of severe ocular involvement of Behçet’s disease. Annual European Congress on Rheumatology-EULAR 2001, 13-16 June 2001

43. A. Dinç MD, M. Uzun MD, S. Pay MD, İ. Şimşek MD, F. Kılıçarslan MD, H erdem MD. Diastolic dysfunction in patients with scleroderma: A tissue doppler study. Annual European Congress on Rheumatology-EULAR 2001, 13-16 June 2001

44.  S. Pay MD, H erdem MD, M. Serdar MD, A. Dinç MD, İ. Şimşek MD, M. Turan MD. Comparison of sinovial MMP-1 and TİMP-1 levels in various inflammatory arthritides. Annual European Congress on Rheumatology-EULAR 2001, 13-16 June 2001

45. H. Aslan MD, S. Pay MD, F. Gök MD, A. Şengül, M. Sağlam, M. Güleç.  Is there any role of anti-annexin V autoantibodies in the thrombotic events of Behçet’s syndrome? Annual European Congress on Rheumatology-EULAR 2001, 13-16 June 2001

46.  M. Tunca MD, H. Özdoğan MD, on behalf of the Turkish FMF Study Group (FMF-TR). The Turkish FMF Study Group (FMF-TR): A brief description. Third International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 23-27 September 2002

47.  M. Tunca MD, S. Akar MD, A. Şirin MD, F. Önen MD, V. Çobankara MD, on behalf of the Turkish FMF Study Group (FMF-TR). The results of a nationwide, multicenter analysis of the clinical and genetic characteristics of the Turkish FMF patients. Third International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 23-27 September 2002

48. H. Özdoğan MD, O. Kasapçopur MD, F. Göğüs MD, S. Maşatlioğlu MD, A. Dinç MD, on behalf of the Turkish FMF Study Group (FMF-TR). Familial Mediterranean Fever is a non-Mediterranean disease in Turkey. Third International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 23-27 September 2002

49. A. Bakkaloğlu MD, S. Özen MD, R. Topaloğlu MD, R. Düşünsel MD, H. Şimşek MD, on behalf of the Turkish FMF Study Group (FMF-TR). Associated diseases in Turkish FMF patients: Are FMF patients predisposed to develop certain vasculitides? Third International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 23-27 September 2002

50.  M. Çalgüneri MD, Ü. Saatçi MD, S. Apraş MD, Y. Kabasakal MD, S. Özen MD, on behalf of the Turkish FMF Study Group (FMF-TR). Musculoskeletal system findings in Turkish FMF patients. Third International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 23-27 September 2002

51.  Ü. Saatçi MD, F. Yalçınkaya MD, A. Öner MD, N. Besbas MD, E. Baskın MD, on behalf of the Turkish FMF Study Group (FMF-TR). Renal involvement in Turkish patients with FMF. Third International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 23-27 September 2002

52. H Tutar MD, N Kara MD, N. Buyan MD, Ö Erdoğan MD, S. Bakkaloğlu MD, on behalf of the Turkish FMF Study Group (FMF-TR). Demographic and clinical features of FMF patients with pericardial attacks. Third International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 23-27 September 2002

53.  F. Yalçınkaya MD, R. Topaloğlu MD, E. Yılmaz MD, S. Emre MD, E. Erken MD, on behalf of the Turkish FMF Study Group (FMF-TR). Distribution of MEFV mutations and phenotype genotype correlation in Turkish patients with FMF: A nationwide data. Third International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 23-27 September 2002

54.  N. Çakar MD, A. Düzova MD, M. Arıcı MD, G. Demircin MD, S. Arslan MD, on behalf of the Turkish FMF Study Group (FMF-TR). Early versus late-onset Familial Mediterranean Fever (FMF). Third International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, 23-27 September 2002

55.  S. Pay, R.A. Terkeltaub, D.M. Rose (Sözlü sunum). The C termini of CXCR-1 and CXCR-2 are responsible for differential monocytic cell migration stimulated by IL-8. 1st Turkish Greek Rheumatology Days, 23-25 May 2003.

56.  Saruhan-Direskeneli G, Inanc M, Fresko I, Akkoc N, Dalkilic E, Erken E, Karaaslan Y, Kinikli G, Oksel F, Pay S, Yucel AE, Yazıcı H, Konice M, Direskeneli H. For the Leflunomide in active RA study group of Turkey (LARG-T) The effects of shared epitope on the clinical response to leflunomide in patients with active rheumatoid arthritis. 1st Turkish Greek Rheumatology Days, 23-25 May 2003

57.  S. Pay, R.A. Terkeltaub, D.M. Rose (Sözlü sunum). The C termini of CXCR-1 and CXCR-2 are responsible for differential monocytic cell migration stimulated by IL-8. Annual European Congress on Rheumatology-EULAR 2003, 18-21 June 2003

58.  Saruhan-Direskeneli G, Inanc M, Fresko I, Akkoc N, Dalkilic E, Erken E, Karaaslan Y, Kinikli G, Oksel F, Pay S, Yucel AE, Yazıcı H, Konice M, Direskeneli H. For the Leflunomide in active RA study group of Turkey (LARG-T) The effects of shared epitope on the clinical response to leflunomide in patients with active rheumatoid arthritis. Annual European Congress on Rheumatology-EULAR 2003, 18-21 June 2003

59.  H. Erdem, K. Başköy, S. Pay, A. Dinç. Pulmonary involvement in patients with Behçet Disease: What do the initial findings say us? Annual European Congress on Rheumatology-EULAR 2003, 18-21 June 2003

60. S. Pay, S Yeşillik, H. Erdem, A. Dinç. The comparison of clinical and laboratory features of female and male patients with SLE. Annual European Congress on Rheumatology-EULAR 2003, 18-21 June 2003

61. H. Erdem, S. Pay, M. Serdar, I. Simsek, A. Dinc, A. Pekel, U. Musabak, M. Turan Synovial neutrophil-attractive chemokine levels in patients with inflammatory arthritides: What cause(s) the influx of neutrophils into synovial fluid? Annual European Congress on Rheumatology-EULAR 2004, 9-12 June 2004

62.  S. Pay, U. Musabak, H. Erdem, I. Simsek, A. Dinc. IL-8 stimulates neutrophil migration via CXCR-1 more than CXCR-2 chemokine receptor. Annual European Congress on Rheumatology-EULAR 2004, 9-12 June 2004

63.  S. Pay, on behalf of Ankara Rheumatology Study Group. A multicenter study of patients with adult onset Still’s disease compared with systemic juvenile idiopathic arthritis: a study from Ankara, Turkey. Annual European Congress on Rheumatology-EULAR 2004, 9-12 June 2004

64.  O.S. Yılmaz, A. Dinç, H. Erdem, İ. Şimşek, S. Pay, A. Pekel. VEGF and TNF-alpha serum levels in patients with Behçet’s uveitis. Annual European Congress on Rheumatology-EULAR 2004, 9-12 June 2004

65.  E. Bozoğlu, A. Dinç, H. Erdem, S. Pay, İ. Şimşek. Serum VEGF and MCP-1 in Behçet’s trombosis. Annual European Congress on Rheumatology-EULAR 2004, 9-12 June 2004

66. M. Güleç, S. Öztürk, S. Pay, Z. Çalışkaner, M. Demiriz, M. Karaayvaz. A case of ANA negative systemic lupus erytthematosus presenting with chronic urticeria. 9th Congress of Balkan Military Medical Committee, 21-24 June 2004

67. S. Pay, U. Musabak, H. Erdem, A. Pekel, I. Simsek, A. Şengül, A. Dinç. Chimerical anti-TNF-a, infliximab, inhibits neutrophil chemotaxis and production of reactive oxygen species by blocking the priming effect of mononuclear cells on neutrophils. 4th Balkan Congress of Immunology-BAIS 2004, 5-8 Semptember 2004

68. H. Erdem, S. Pay, M. Serdar, I. Simsek, A. Dinc, A. Pekel, U. Musabak, M. Turan Synovial neutrophil-attractive chemokine levels in patients with inflammatory arthritides: What cause(s) the influx of neutrophils into synovial fluid? 4th Balkan Congress of Immunology-BAIS 2004, 5-8 Semptember 2004

69.  S. Pay, A. Pekel, I. Simsek, U. Musabak, H. Erdem, A. Dinç, A. Şengül. Expression of CXCR-1 and CXCR-2 chemokine receptors on neutrophils in inflammatory arthritides: Does persistant expression of CXCR2 contribute to the erosive changes? 4th Balkan Congress of Immunology-BAIS 2004, 5-8 Semptember 2004

70. S. Pay, U. Musabak, H. Erdem, I. Simsek, A. Dinc IL-8 stimulates neutrophil migration via CXCR-1 more than CXCR-2 chemokine receptor. 4th Balkan Congress of Immunology-BAIS 2004, 5-8 Semptember 2004

71. H. Erdem, S. Pay, M. Serdar, I. Simsek, A. Dinc, A. Pekel, U. Musabak, M. Turan Synovial ELR(+) (Angiogenic) CXC Chemokine Expression in Patients with Inflammatory Arthritides: Do Lower Levels Prevent the Development of Pannus and Sequential Erosive Changes in Patients with Behçet’s Disease. XI. International Conference on Behçet’s disease, 27-31 October 2004

72.  S. Pay, A. Pekel, I. Simsek, U. Musabak, H. Erdem, A. Dinç, A. Şengül. (Sözlü sunum) Expression of CXCR-1 and CXCR-2 chemokine receptors on neutrophils in inflammatory arthritides: Does persistant expression of CXCR2 contribute to the erosive changes? XI. International Conference on Behçet’s disease, 27-31 October 2004  

73. Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, Sengul A. Correlation of Serum IL-18 Levels with Disease Activity and Clinical Presentation in Patients with Behçet’s Disease. XI. International Conference on Behçet’s disease, 27-31 October 2004

74. Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A Synovial Proinflammatory Cytokine Expression and Its Correlation with MMP-3 Levels in Behçet’s Disease. XI. International Conference on Behçet’s disease, 27-31 October 2004

75.  Aslan H, Aldemir D, Pay S, Öğüş E, Gök F, Türkoğlu S. (Sözlü sunum) Serum homocysteine and cysteine levels and their relations with the thrombosis in patients with Behçet’s disease. XI. International Conference on Behçet’s disease, 27-31 October 2004

76. Erdem H, Taslipinar A, Dinc A, Saglam M, Simsek I, Uysal Y, Pay S . Submandibular Lymph Nodes in Uveitis. XI. International Conference on Behçet’s disease, 27-31 October 2004

77. Erdem H, Dinc A, Simsek I, Pay S A Neurobehçet’s Case Complicated with Intracranial Hypertension Succesfully Treated by a Lumboperitoneal Shunt. XI. International Conference on Behçet’s disease, 27-31 October 2004

78. Dinc A, Bayır A, Simsek I, Erdem H, Pay S (Sözlü sunum). The Proportional Venn diagram of Clinical Features seen in Behçet’s Disease. XI. International Conference on Behçet’s disease, 27-31 October 2004

79. Yilmaz OS, Dinc A, Erdem H, Simsek I, Pay S, Pekel A Vascular Endothelial Growth Factor (VEGF) and Tumor Necrosis Factor – Alpha (TNF- α) Serum Levels in Patients with Behçet’s Uveitis XI. International Conference on Behçet’s disease, 27-31 October 2004

80. Bozoglu E, Dinc A, Erdem H, Pay S, Simsek I (Sözlü sunum). Serum Vascular Endothelial Growth Factor (VEGF) and Monocyte Chemoattractant Protein -1 (MCP-1) Levels In Behçet’s Thrombosis. XI. International Conference on Behçet’s disease, 27-31 October 2004

81. Pay S, Musabak U, Erdem H, Pekel A, Simsek İ, Şengül A, Dinç A. Chimerical anti-TNF-a, infliximab, inhibits neutrophil function by blocking the priming effect of phytohemagglutinin-stimulated human peripheral blood mononuclear cells on neutrophils. Annual European Congress on Rheumatology-EULAR 2005, 7-11 June 2005

82. Pay S, Musabak U, Simsek İ, Pekel A, Erdem H, Dinç A, Şengül A. Expression of CXCR-1 and CXCR-2 chemokine receptors on synovial neutrophils in inflammatory arthritides: Does persistent or increasing expression of CXCR2 contribute to the chronic inflammation or erosive changes? Annual European Congress on Rheumatology-EULAR 2005, 7-11 June 2005

83. Musabak U, Pay S, Erdem H, Simsek I, Pekel A, Dinc A, Sengul A. Serum Interleukin-18 Levels in Patients with Behçet’s Disease: Is Its Expression Associated with Disease Activity or Clinical Presentations? Annual European Congress on Rheumatology-EULAR 2005, 7-11 June 2005

84. Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A. Synovial Proinflammatory Cytokines and Their Correlation with Matrix Metalloproteinase-3 Expression in Behçet’s Disease: Does Interleukin-1b Play a Major Role in Behçet’s Synovitis? Annual European Congress on Rheumatology-EULAR 2005, 7-11 June 2005

85. Odabaşı E, Erdem H, Serdar M, Turan M, Tekin R, Pay S. The effect of mud pack treatment in knee osteoarthritis: A single blind clinical study. 35th Congress of The International Society of Medical Hydrology & Climatology6-10 June 2006

86. Erdem H, Pay S, Musabak U, Şimsek I, Dinc A, Pekel A, Sengul A. Synovial Angiostatic Non-ELR(+) CXC Chemokines in Inflammatory Arthritides. Annual European Congress on Rheumatology-EULAR 2006, 21-24 June 2006

87. Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdoğan A, Sengul A, Dinc A, Ankara Rheumatology Study Group. Serum MMP-2 and MMP-9 Levels in Patients with Behçet’s Disease: Do They Correlate to Vasculo-Behçet’s Disease Associated with Aneurysm Formation? Annual European Congress on Rheumatology-EULAR 2006, 21-24 June 2006

88. Simsek I, Pay S, Pekel A, Dinc A, Musabak U, Erdem H, Sengul A. Serum Proinflammatory Cytokines Directing T Helper 1 Polarization in Patients with Familial Mediterranean Fever. Annual European Congress on Rheumatology-EULAR 2006, 21-24 June 2006

89. Pay S, Musabak U, Simsek I, Erdem H, Pekel A, Sengul A, Dinc A. Synovial Lymphoid Neogenetic Factors in Behçet’s Disease:  Are SDF-1/CXCL12 and BCL/CXCL13 Responsible For Subacute Course of Arthritis? Annual European Congress on Rheumatology-EULAR 2006, 21-24 June 2006

90. Simsek I, Çınar M, Erdem H, Dinç A, Pay S, Çalışkaner Z. Tuberculin skin test and anergy in patients with ankylosing spondylitis before anti-TNF therapy. Annual European Congress on Rheumatology-EULAR 2006, 21-24 June 2006

91. Erdem H, Pay S, Musabak U, Şimsek I, Dinc A, Pekel A, Sengul A. Synovial Angiostatic Non-ELR(+) CXC Chemokines in Inflammatory Arthritides. XII. International Conference on Behçet’s disease, 19-23 October 2006

92. Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdoğan A, Sengul A, Dinc A, Ankara Rheumatology Study Group. (Sözlü sunum) Serum MMP-2 and MMP-9 Levels in Patients with Behçet’s Disease: Do They Correlate to Vasculo-Behçet’s Disease Associated with Aneurysm Formation? XII. International Conference on Behçet’s disease, 19-23 October 2006

93. Pay S, Musabak U, Simsek I, Erdem H, Pekel A, Sengul A, Dinc A. (Sözlü sunum) Synovial Lymphoid Neogenetic Factors in Behçet’s Disease:  Are SDF-1/CXCL12 and BCL/CXCL13 Responsible For Subacute Course of Arthritis? XII. International Conference on Behçet’s disease, 19-23 October 2006

94. Pay S, Simsek I, Erdem H, Pekel A, Musabak U, Sengul A, Dinc A. (Sözlü sunum) Quantitative and Functional Analysis of Dendritic Cell Subsets in Behçet’s Disease: Does Functional Abnormality in Plasmacytoid Dendtritic Cell Contribute to Th1 Polarization? XII. International Conference on Behçet’s disease, 19-23 October 2006

95. Dinc A, Simsek I, Meriç C, Erdem H, Pay S. (Sözlü sunum) Comparison of patient-declared clinical events obtained and every day and once a month in patients with Behçet’s disease: A need for a new disease activity scoring system. XII. International Conference on Behçet’s disease, 19-23 October 2006

96. Simsek I, Meriç C, Erdem H, Pay S, Köse O, Dinc A. Correlation between patient-reported clinical activity and well-being obtained on a daily basis in Behçet’s patients followed for two months. XII. International Conference on Behçet’s disease, 19-23 October 2006

97. Köse O Simsek I, Dinç A, Pay S, , Dinc A. (Sözlü sunum) Mycophenolate sodium is effective in the treatment of resistant muco-cutaneous Behçet’s disease (preliminary report). XII. International Conference on Behçet’s disease, 19-23 October 2006

98. Pay S, Şimşek İ, Erdem H, Pekel A, Muşabak U, Şengül A, Dinç A. Quantitative and functional analysis of dendritic cell subsets in Behçet’s disease: Does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization? Annual European Congress on Rheumatology-EULAR 2007, 11-16 June 2007

99. Çınar M, Dinç A, Şimşek İ, Erdem H, Koç B, Pay S, Kılıç S. The rate and predictors of response to non-steroidal anti-inflammatory drugs among patients with spondyloarthropathies: A three months, prospective, observational study. Annual European Congress on Rheumatology-EULAR 2007, 11-16 June 2007

100. Şimşek İ, Erdem H, Pay S, Sobacı G, Dinç A. Optic neuritis occurring with anti-tumor necrosis factor-alpha therapy. Annual European Congress on Rheumatology-EULAR 2007, 11-16 June 2007